Canagliflozin increases adenoma burden in female APCMin/+ mice
J. L. Korfhage, M. E. Skinner, J. Basu, J. K. Greenson, R. A. Miller, D. B. Lombard
This study shows that canagliflozin increases adenoma burden in female APCMin/+ mice, suggesting complex, cell-non-autonomous mechanisms and sex differences in drug effects.
bioRxiv · Mar 27, 2021Cancer Biology